CellSeed Inc.

7776

JP3423530009

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 07:00:00 16/05/2024 BST			5-day change	1st Jan Change
220 ^JPY	-7.56%		+1.85%	-18.82%

2023	CellSeed Inc. announced that it has received ¥2.001 million in funding from Barclays Bank PLC, Investment Arm	CI
2023	CellSeed Inc. announced that it expects to receive Â¥2.001 million in funding from Barclays Bank PLC, Investment Arm	CI

CellSeed Inc. announced that it has received ¥6.4 million in funding from Milestone Capital Management Co., Ltd.

August 30, 2015

On August 31, 2015, CellSeed Inc. (JASDAQ:7776) closed the transaction.

Latest news about CellSeed Inc.

CellSeed Inc. announced that it has received ¥2.001 million in funding from Barclays Bank PLC, Investment Arm	04/06/23	CI
CellSeed Inc. announced that it expects to receive Â¥2.001 million in funding from Barclays Bank PLC, Investment Arm	14/05/23	CI
CellSeed Inc. announced that it has received ¥1.144 million in funding from Barclays Bank PLC, Investment Arm	04/01/22	CI
CellSeed Inc. announced that it expects to receive ¥1.144 million in funding from Barclays Bank PLC, Investment Arm	19/12/21	CI
CellSeed Inc. announced that it has received ¥3.78 million in funding from Barclays Bank PLC, Investment Arm	05/08/20	CI
CellSeed Inc. announced that it expects to receive ¥3.78 million in funding from Barclays Bank PLC, Investment Arm	20/07/20	CI
CellSeed Inc. announced that it has received ¥2.884 million in funding	01/09/19	CI
An unknown buyer acquired 0.34% stake in CellSeed Inc. from Emmaus Life Sciences, Inc. for $0.22 million.	13/08/19	CI
CellSeed Inc. announced that it expects to receive ¥2.884 million in funding	13/08/19	CI
CellSeed Inc. announced that it has received ¥6.6 million in funding from Evolution Capital Management, LLC	05/03/17	CI
CellSeed Inc. announced that it expects to receive ¥6.6 million in funding from Evolution Capital Management, LLC	16/02/17	CI
CellSeed Inc.(JASDAQ:7776) dropped from S&P Global BMI Index	21/09/15	CI
CellSeed Inc. announced that it has received ¥6.4 million in funding from Milestone Capital Management Co., Ltd.	30/08/15	CI
CellSeed Inc. announced that it expects to receive ¥6.4 million in funding from Milestone Capital Management Co., Ltd..	12/08/15	CI
CellSeed Inc. Announces Management Changes	27/05/14	CI
CellSeed Inc. announced that it has received ¥509.33 million in funding from Whiz Partners Inc.	20/03/14	CI
CellSeed Inc. announced that it expects to receive ¥509.33 million in funding from Whiz Partners Inc.	04/03/14	CI
CellSeed Inc. announced that it has received ¥3.10 billion in funding from UBS AG London branch, Investment Arm.	02/09/13	CI
CellSeed Inc. announced that it has received ¥173.44 million in funding from Milestone Capital Management Co., Ltd.	27/12/12	CI
CellSeed Inc. announced that it expects to receive ¥173.44 million in funding from Milestone Capital Management Co., Ltd.	11/12/12	CI
CellSeed Inc. Reports Earnings Results for the Fiscal Year of 2011; Provides Earnings Guidance for the Fiscal Year 2012	21/03/12	CI

CellSeed Inc. is mainly engaged in the regenerative medical business. The Company operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
CELLSEED INC.	-18.82%	49.45M
CSL LIMITED	+0.10%	91.42B
SAMSUNG BIOLOGICS CO.,LTD.	+2.76%	41.08B
BIOGEN INC.	-9.06%	34.26B
UCB	+54.37%	25.27B
BIOMARIN PHARMACEUTICAL INC.	-16.61%	15.27B
INCYTE CORPORATION	-9.14%	12.81B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12.11%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.61%	11.42B
SWEDISH ORPHAN BIOVITRUM AB	+5.32%	9.16B

Biopharmaceuticals

CellSeed Inc.

Equities

7776

JP3423530009

Pharmaceuticals

CellSeed Inc. announced that it has received ¥6.4 million in funding from Milestone Capital Management Co., Ltd.

Latest news about CellSeed Inc.

Chart CellSeed Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Biopharmaceuticals